(lp0
S'MEI Pharma Reports Second Quarter Fiscal Year 2017 Results PR Newswire  - Feb 8, 2017 SAN DIEGO, Feb. 8, 2017 /PRNewswire/ -- MEI Pharma, Inc. , an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its second quarter ended December 31, 2016.MEI Pharma, Inc.  Sees Strong Trading Volume Following Strong Earnings - The Cerbat GemMEI Pharma, Inc.  Releases Quarterly Earnings Results, Beats Estimates ... - BBNS'
p1
aS'MEI Pharma to Present at Oppenheimer Healthcare Conference Yahoo Finance - Mar 14, 2017 SAN DIEGO, March 14, 2017 /PRNewswire/ -- MEI Pharma, Inc. , an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.In Volatile Markets Do Analysts Think You Should Buy MEI Pharma, Inc. ? - The De Soto EdgeBasic Consolidated EPS Of MEI Pharma, Inc.  At $-0.6065 - Equities Focus'
p2
aS'1.65 MarketWatch - Aug 15, 2012 MEI Pharma, Inc. is an oncology company, which engages in clinical development of novel small molecules for the treatment of cancer.'
p3
aS'BRIEF-MEI Pharma posts Q2 earnings per share $0.32 Reuters - Feb 8, 2017 Feb 8 Boeing Co is the front-runner as Singapore Airlines Ltd is closing in on a 35 wide-body aircraft order amid a battle with Chinese and Middle Eastern carriers, Bloomberg reported, citing sources.'
p4
aS"MEI Pharma Inc  Poised To Move Higher; Here's Why Smarter Analyst - Apr 19, 2016 Having seen the updated Pracinostat overall survival data in elderly Acute Myeloid Leukemia  from MEI Pharma  presented at the recent Needham Healthcare Conference, I believe this is another opportunity to buy a severely&nbsp;..."
p5
aS"Helsinn Group and MEI Pharma Enter Strategic Agreement for the Development and ... PR Newswire  - Aug 8, 2016 LUGANO, Switzerland and SAN DIEGO, Aug. 8, 2016 /PRNewswire/ -- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. , an oncology company focused on the clinical development&nbsp;...What MEI Pharma Inc 's $444 Million Deal Really Means - Scibility MediaMEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff - Xconomy"
p6
aS"MEI Pharma's Pracinostat Receives Breakthrough Therapy Designation from FDA ... PR Newswire  - Aug 1, 2016 SAN DIEGO, Aug. 1, 2016 /PRNewswire/ -- MEI Pharma, Inc. , an oncology company focused on the clinical development of novel therapies for cancer, announced today that the U.S.Pracinostat Granted Breakthrough Therapy Designation for AML in Elderly Patients - Cancer Therapy Advisor"
p7
aS'Wedbush Top Analyst Remains Sidelined on MEI Pharma Inc  Despite ... Smarter Analyst - Aug 3, 2016 MEI Pharma Inc  just received Breakthrough Therapy Designation for its key pipeline drug pracinostat, anti-tumor molecule inhibitor that combined with azacitidine treats patients with newly diagnosed acute myeloid leukemia  who are&nbsp;...'
p8
aS'MEI Pharma: Upcoming Catalysts Will Drive Stock Rebound Seeking Alpha  - Mar 24, 2015 The ~80% gain in MEI Pharma  in less than 2 months since my article was too much for me to pass up completely as I hedged my bet.MEI Pharma Announces Top-Line Data From Randomized Phase II Clinical Study Of ... - PR Newswire Can MEI Pharma Survive? - 24/7 Wall St.'
p9
aS'MEI Pharma Should Be Bought Ahead Of ASH Conference Seeking Alpha - Nov 4, 2015 Pracinostat Phase 2 data presented at ASH will illustrate survival benefit in AML and favorable outcomes in MDS patients. MEI Pharma also has two other promising clinical stage drugs in the pipeline with PWT143,  and a novel&nbsp;...'
p10
a.